Home > > > > > Report Detail

Global Blood Product Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Publisher Name :
Date: 14-Sep-2022
No. of pages: 132
Inquire Before Buying

Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.

Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Blood Product market is projected to reach US$ 47570 million by 2028 from an estimated US$ 30660 million in 2022, at a CAGR of 7.6% during 2023 and 2028.

The major players in global blood product market include Takeda, CSL, etc. The top 3 players occupy about 60% shares of the global market. North America and Europe are main markets, they occupy about 65% of the global market.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Blood Product, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Blood Product.

The Blood Product market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Blood Product market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Blood Product companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

- Takeda

- CSL

- Grifols

- Octapharma

- Kedrion

- LFB Group

- Biotest

- BPL

- Shanghai RAAS

- China Biologic Products

- Hualan Biological Engineering Inc.

- Beijing Tiantan Biological Products Corp

- Pacific Shuanglin

- Boya Bio-Pharmaceutical

- Paisi Feike Biology Pharmacy Co., Ltd.

- Xinjiang Deyuan Bioengineering

- Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.

- Shenzhen Weiguang

- Shanxi Kangbao

- Nanyue Biopharming Corporation Ltd

Product Type Insights

Global markets are presented by Blood Product type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Blood Product are procured by the companies.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Blood Product Segment by Type

- Albumin

- Immunoglobulin

- Clotting Factor

- Others

Application Insights

This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).

This report also outlines the market trends of each segment and consumer behaviors impacting the Blood Product market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Blood Product market.

Blood Product Segment by Application

- Bleeding Wound

- Immunodeficiency

- HBV

- Tetanus

- Rabies

- Hemophilia

- Others

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue of each region and country for the period 2017-2028.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Southeast Asia

- - Australia

- - Rest of Asia-Pacific

- Latin America

- - Mexico

- - Brazil

- - Argentina

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Blood Product market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood Product market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Blood Product and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Blood Product industry.

This report helps stakeholders to gain insights into which regions to target globally.

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood Product.

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Global Blood Product Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Table of Contents
1 Study Coverage
1.1 Blood Product Product Introduction
1.2 Market by Type
1.2.1 Global Blood Product Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Albumin
1.2.3 Immunoglobulin
1.2.4 Clotting Factor
1.2.5 Others
1.3 Market by Application
1.3.1 Global Blood Product Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Bleeding Wound
1.3.3 Immunodeficiency
1.3.4 HBV
1.3.5 Tetanus
1.3.6 Rabies
1.3.7 Hemophilia
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Blood Product Market Size Estimates and Forecasts
2.2 Blood Product Market Size by Region: 2022 Versus 2028
2.2.1 Global Blood Product Revenue by Region: 2017-2022
2.2.2 Global Blood Product Revenue Forecast by Region (2023-2028)
2.2.3 Global Blood Product Revenue Market Share by Region (2017-2028)
3 Global Blood Product by Company
3.1 Global Blood Product Revenue by Company (2017-2022)
3.2 Global Blood Product Revenue Share by Company (2017-2022)
3.3 Competitive Landscape
3.3.1 Key Blood Product Companies around the World: Ranking by Revenue
3.3.2 Global Blood Product Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.3.3 Global Blood Product Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.4 Global Blood Product Companies Headquarters & Product Type
3.4.1 Blood Product Companies Headquarters
3.4.2 Global Blood Product Companies Product & Service
3.4.3 Date of International Companies Enter into Blood Product Market
3.5 Global Blood Product Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Takeda
4.1.1 Takeda Corporation Information
4.1.2 Takeda Description, Business Overview
4.1.3 Takeda Blood Product Products Offered
4.1.4 Takeda Blood Product Revenue and Gross Margin (2017-2022)
4.1.5 Takeda Blood Product Revenue by Product in 2021
4.1.6 Takeda Blood Product Revenue by Application in 2021
4.1.7 Takeda Blood Product Revenue by Geographic Area in 2021
4.1.8 Takeda Recent Developments
4.2 CSL
4.2.1 CSL Corporation Information
4.2.2 CSL Description, Business Overview
4.2.3 CSL Blood Product Products Offered
4.2.4 CSL Blood Product Revenue and Gross Margin (2017-2022)
4.2.5 CSL Blood Product Revenue by Product in 2021
4.2.6 CSL Blood Product Revenue by Application in 2021
4.2.7 CSL Blood Product Revenue by Geographic Area in 2021
4.2.8 CSL Recent Developments
4.3 Grifols
4.3.1 Grifols Corporation Information
4.3.2 Grifols Description, Business Overview
4.3.3 Grifols Blood Product Products Offered
4.3.4 Grifols Blood Product Revenue and Gross Margin (2017-2022)
4.3.5 Grifols Blood Product Revenue by Product in 2021
4.3.6 Grifols Blood Product Revenue by Application in 2021
4.3.7 Grifols Blood Product Revenue by Geographic Area in 2021
4.3.8 Grifols Recent Developments
4.4 Octapharma
4.4.1 Octapharma Corporation Information
4.4.2 Octapharma Description, Business Overview
4.4.3 Octapharma Blood Product Products Offered
4.4.4 Octapharma Blood Product Revenue and Gross Margin (2017-2022)
4.4.5 Octapharma Blood Product Revenue by Product in 2021
4.4.6 Octapharma Blood Product Revenue by Application in 2021
4.4.7 Octapharma Blood Product Revenue by Geographic Area in 2021
4.4.8 Octapharma Recent Developments
4.5 Kedrion
4.5.1 Kedrion Corporation Information
4.5.2 Kedrion Description, Business Overview
4.5.3 Kedrion Blood Product Products Offered
4.5.4 Kedrion Blood Product Revenue and Gross Margin (2017-2022)
4.5.5 Kedrion Blood Product Revenue by Product in 2021
4.5.6 Kedrion Blood Product Revenue by Application in 2021
4.5.7 Kedrion Blood Product Revenue by Geographic Area in 2021
4.5.8 Kedrion Recent Developments
4.6 LFB Group
4.6.1 LFB Group Corporation Information
4.6.2 LFB Group Description, Business Overview
4.6.3 LFB Group Blood Product Products Offered
4.6.4 LFB Group Blood Product Revenue and Gross Margin (2017-2022)
4.6.5 LFB Group Blood Product Revenue by Product in 2021
4.6.6 LFB Group Blood Product Revenue by Application in 2021
4.6.7 LFB Group Blood Product Revenue by Geographic Area in 2021
4.6.8 LFB Group Recent Development
4.7 Biotest
4.7.1 Biotest Corporation Information
4.7.2 Biotest Description, Business Overview
4.7.3 Biotest Blood Product Products Offered
4.7.4 Biotest Blood Product Revenue and Gross Margin (2017-2022)
4.7.5 Biotest Blood Product Revenue by Product in 2021
4.7.6 Biotest Blood Product Revenue by Application in 2021
4.7.7 Biotest Blood Product Revenue by Geographic Area in 2021
4.7.8 Biotest Recent Development
4.8 BPL
4.8.1 BPL Corporation Information
4.8.2 BPL Description, Business Overview
4.8.3 BPL Blood Product Products Offered
4.8.4 BPL Blood Product Revenue and Gross Margin (2017-2022)
4.8.5 BPL Blood Product Revenue by Product in 2021
4.8.6 BPL Blood Product Revenue by Application in 2021
4.8.7 BPL Blood Product Revenue by Geographic Area in 2021
4.8.8 BPL Recent Development
4.9 Shanghai RAAS
4.9.1 Shanghai RAAS Corporation Information
4.9.2 Shanghai RAAS Description, Business Overview
4.9.3 Shanghai RAAS Blood Product Products Offered
4.9.4 Shanghai RAAS Blood Product Revenue and Gross Margin (2017-2022)
4.9.5 Shanghai RAAS Blood Product Revenue by Product in 2021
4.9.6 Shanghai RAAS Blood Product Revenue by Application in 2021
4.9.7 Shanghai RAAS Blood Product Revenue by Geographic Area in 2021
4.9.8 Shanghai RAAS Recent Development
4.10 China Biologic Products
4.10.1 China Biologic Products Corporation Information
4.10.2 China Biologic Products Description, Business Overview
4.10.3 China Biologic Products Blood Product Products Offered
4.10.4 China Biologic Products Blood Product Revenue and Gross Margin (2017-2022)
4.10.5 China Biologic Products Blood Product Revenue by Product in 2021
4.10.6 China Biologic Products Blood Product Revenue by Application in 2021
4.10.7 China Biologic Products Blood Product Revenue by Geographic Area in 2021
4.10.8 China Biologic Products Recent Development
4.11 Hualan Biological Engineering Inc.
4.11.1 Hualan Biological Engineering Inc. Corporation Information
4.11.2 Hualan Biological Engineering Inc. Description, Business Overview
4.11.3 Hualan Biological Engineering Inc. Blood Product Products Offered
4.11.4 Hualan Biological Engineering Inc. Blood Product Revenue and Gross Margin (2017-2022)
4.11.5 Hualan Biological Engineering Inc. Blood Product Revenue by Product in 2021
4.11.6 Hualan Biological Engineering Inc. Blood Product Revenue by Application in 2021
4.11.7 Hualan Biological Engineering Inc. Blood Product Revenue by Geographic Area in 2021
4.11.8 Hualan Biological Engineering Inc. Recent Development
4.12 Beijing Tiantan Biological Products Corp
4.12.1 Beijing Tiantan Biological Products Corp Corporation Information
4.12.2 Beijing Tiantan Biological Products Corp Description, Business Overview
4.12.3 Beijing Tiantan Biological Products Corp Blood Product Products Offered
4.12.4 Beijing Tiantan Biological Products Corp Blood Product Revenue and Gross Margin (2017-2022)
4.12.5 Beijing Tiantan Biological Products Corp Blood Product Revenue by Product in 2021
4.12.6 Beijing Tiantan Biological Products Corp Blood Product Revenue by Application in 2021
4.12.7 Beijing Tiantan Biological Products Corp Blood Product Revenue by Geographic Area in 2021
4.12.8 Beijing Tiantan Biological Products Corp Recent Development
4.13 Pacific Shuanglin
4.13.1 Pacific Shuanglin Corporation Information
4.13.2 Pacific Shuanglin Description, Business Overview
4.13.3 Pacific Shuanglin Blood Product Products Offered
4.13.4 Pacific Shuanglin Blood Product Revenue and Gross Margin (2017-2022)
4.13.5 Pacific Shuanglin Blood Product Revenue by Product in 2021
4.13.6 Pacific Shuanglin Blood Product Revenue by Application in 2021
4.13.7 Pacific Shuanglin Blood Product Revenue by Geographic Area in 2021
4.13.8 Pacific Shuanglin Recent Development
4.14 Boya Bio-Pharmaceutical
4.14.1 Boya Bio-Pharmaceutical Corporation Information
4.14.2 Boya Bio-Pharmaceutical Description, Business Overview
4.14.3 Boya Bio-Pharmaceutical Blood Product Products Offered
4.14.4 Boya Bio-Pharmaceutical Blood Product Revenue and Gross Margin (2017-2022)
4.14.5 Boya Bio-Pharmaceutical Blood Product Revenue by Product in 2021
4.14.6 Boya Bio-Pharmaceutical Blood Product Revenue by Application in 2021
4.14.7 Boya Bio-Pharmaceutical Blood Product Revenue by Geographic Area in 2021
4.14.8 Boya Bio-Pharmaceutical Recent Development
4.15 Paisi Feike Biology Pharmacy Co., Ltd.
4.15.1 Paisi Feike Biology Pharmacy Co., Ltd. Corporation Information
4.15.2 Paisi Feike Biology Pharmacy Co., Ltd. Description, Business Overview
4.15.3 Paisi Feike Biology Pharmacy Co., Ltd. Blood Product Products Offered
4.15.4 Paisi Feike Biology Pharmacy Co., Ltd. Blood Product Revenue and Gross Margin (2017-2022)
4.15.5 Paisi Feike Biology Pharmacy Co., Ltd. Blood Product Revenue by Product in 2021
4.15.6 Paisi Feike Biology Pharmacy Co., Ltd. Blood Product Revenue by Application in 2021
4.15.7 Paisi Feike Biology Pharmacy Co., Ltd. Blood Product Revenue by Geographic Area in 2021
4.15.8 Paisi Feike Biology Pharmacy Co., Ltd. Recent Development
4.16 Xinjiang Deyuan Bioengineering
4.16.1 Xinjiang Deyuan Bioengineering Corporation Information
4.16.2 Xinjiang Deyuan Bioengineering Description, Business Overview
4.16.3 Xinjiang Deyuan Bioengineering Blood Product Products Offered
4.16.4 Xinjiang Deyuan Bioengineering Blood Product Revenue and Gross Margin (2017-2022)
4.16.5 Xinjiang Deyuan Bioengineering Blood Product Revenue by Product in 2021
4.16.6 Xinjiang Deyuan Bioengineering Blood Product Revenue by Application in 2021
4.16.7 Xinjiang Deyuan Bioengineering Blood Product Revenue by Geographic Area in 2021
4.16.8 Xinjiang Deyuan Bioengineering Recent Development
4.17 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
4.17.1 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Corporation Information
4.17.2 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Description, Business Overview
4.17.3 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Blood Product Products Offered
4.17.4 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Blood Product Revenue and Gross Margin (2017-2022)
4.17.5 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Blood Product Revenue by Product in 2021
4.17.6 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Blood Product Revenue by Application in 2021
4.17.7 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Blood Product Revenue by Geographic Area in 2021
4.17.8 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Recent Development
4.18 Shenzhen Weiguang
4.18.1 Shenzhen Weiguang Corporation Information
4.18.2 Shenzhen Weiguang Description, Business Overview
4.18.3 Shenzhen Weiguang Blood Product Products Offered
4.18.4 Shenzhen Weiguang Blood Product Revenue and Gross Margin (2017-2022)
4.18.5 Shenzhen Weiguang Blood Product Revenue by Product in 2021
4.18.6 Shenzhen Weiguang Blood Product Revenue by Application in 2021
4.18.7 Shenzhen Weiguang Blood Product Revenue by Geographic Area in 2021
4.18.8 Shenzhen Weiguang Recent Development
4.19 Shanxi Kangbao
4.19.1 Shanxi Kangbao Corporation Information
4.19.2 Shanxi Kangbao Description, Business Overview
4.19.3 Shanxi Kangbao Blood Product Products Offered
4.19.4 Shanxi Kangbao Blood Product Revenue and Gross Margin (2017-2022)
4.19.5 Shanxi Kangbao Blood Product Revenue by Product in 2021
4.19.6 Shanxi Kangbao Blood Product Revenue by Application in 2021
4.19.7 Shanxi Kangbao Blood Product Revenue by Geographic Area in 2021
4.19.8 Shanxi Kangbao Recent Development
4.20 Nanyue Biopharming Corporation Ltd
4.20.1 Nanyue Biopharming Corporation Ltd Corporation Information
4.20.2 Nanyue Biopharming Corporation Ltd Description, Business Overview
4.20.3 Nanyue Biopharming Corporation Ltd Blood Product Products Offered
4.20.4 Nanyue Biopharming Corporation Ltd Blood Product Revenue and Gross Margin (2017-2022)
4.20.5 Nanyue Biopharming Corporation Ltd Blood Product Revenue by Product in 2021
4.20.6 Nanyue Biopharming Corporation Ltd Blood Product Revenue by Application in 2021
4.20.7 Nanyue Biopharming Corporation Ltd Blood Product Revenue by Geographic Area in 2021
4.20.8 Nanyue Biopharming Corporation Ltd Recent Development
5 Breakdown Data by Type
5.1 Global Blood Product Revenue by Type (2017-2022)
5.2 Global Blood Product Revenue Forecast by Type (2023-2028)
5.3 Blood Product Revenue Marke Share by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Blood Product Revenue by Application (2017-2022)
6.2 Global Blood Product Revenue Forecast by Application (2023-2028)
6.3 Blood Product Revenue Market Share by Application (2017-2028)
7 North America
7.1 North America Blood Product Market Size YoY Growth 2017-2028
7.2 North America Blood Product Market Facts & Figures by Country (2017-2028)
7.3 North America Blood Product Revenue by Type (2017-2022)
7.4 North America Blood Product Revenue by Application (2017-2022)
8 Asia-Pacific
8.1 Asia-Pacific Blood Product Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Blood Product Market Facts & Figures by Region (2017-2028)
8.3 Asia-Pacific Blood Product Revenue by Type (2017-2022)
8.4 Asia-Pacific Blood Product Revenue by Application (2017-2022)
9 Europe
9.1 Europe Blood Product Market Size YoY Growth 2017-2028
9.2 Europe Blood Product Market Facts & Figures by Country (2017-2028)
9.3 Europe Blood Product Revenue by Type (2017-2022)
9.4 Europe Blood Product Revenue by Application (2017-2022)
10 Latin America
10.1 Latin America Blood Product Market Size YoY Growth 2017-2028
10.2 Latin America Blood Product Market Facts & Figures by Country (2017-2028)
10.3 Latin America Blood Product Revenue by Type (2017-2022)
10.4 Latin America Blood Product Revenue by Application (2017-2022)
11 Middle East and Africa
11.1 Middle East and Africa Blood Product Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Blood Product Market Facts & Figures by Country (2017-2028)
11.3 Middle East and Africa Blood Product Revenue by Type (2017-2022)
11.4 Middle East and Africa Blood Product Revenue by Application (2017-2022)
12 Supply Chain and Sales Channel Analysis
12.1 Blood Product Supply Chain Analysis
12.2 Blood Product Key Raw Materials and Upstream Suppliers
12.3 Blood Product Clients Analysis
12.4 Blood Product Sales Channel and Sales Model Analysis
12.4.1 Blood Product Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Blood Product Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Blood Product Distributors
13 Market Dynamics
13.1 Blood Product Industry Trends
13.2 Blood Product Market Drivers
13.3 Blood Product Market Challenges
13.4 Blood Product Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Blood Product Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Major Companies of Albumin
Table 3. Major Companies of Immunoglobulin
Table 4. Major Companies of Clotting Factor
Table 5. Major Companies of Others
Table 6. Global Blood Product Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Blood Product Market Size by Region (US$ Million): 2022 VS 2028
Table 8. Global Blood Product Revenue by Region (2017-2022) & (US$ Million)
Table 9. Global Blood Product Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 10. Blood Product Revenue by Company (2017-2022) & (US$ Million)
Table 11. Blood Product Revenue Share by Company (2017-2022)
Table 12. Ranking of Global Top Blood Product Players by Revenue (US$ Million) in 2021
Table 13. Global Blood Product Companies Market Concentration Ratio (CR5 and HHI) & (2017-2022)
Table 14. Global Blood Product by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Blood Product as of 2021)
Table 15. Global Blood Product Companies Headquarters
Table 16. Global Blood Product Companies Product & Service
Table 17. Date of International Companies Enter into Blood Product Market
Table 18. Global Blood Product Mergers & Acquisitions, Expansion Plans
Table 19. Takeda Corporation Information
Table 20. Takeda Description and Business Overview
Table 21. Takeda Blood Product Revenue (US$ Million) and Gross Margin (2017-2022)
Table 22. Takeda Blood Product Product
Table 23. Takeda Blood Product Revenue Proportion of Blood Product by Product in 2021
Table 24. Takeda Blood Product Revenue Proportion of Blood Product by Application in 2021
Table 25. Takeda Blood Product Revenue Proportion of Blood Product by Geographic Area in 2021
Table 26. Takeda Recent Development
Table 27. CSL Corporation Information
Table 28. CSL Description and Business Overview
Table 29. CSL Blood Product Revenue (US$ Million) and Gross Margin (2017-2022)
Table 30. CSL Blood Product Product
Table 31. CSL Blood Product Revenue Proportion of Blood Product by Product in 2021
Table 32. CSL Blood Product Revenue Proportion of Blood Product by Application in 2021
Table 33. CSL Blood Product Revenue Proportion of Blood Product by Geographic Area in 2021
Table 34. CSL Recent Development
Table 35. Grifols Corporation Information
Table 36. Grifols Description and Business Overview
Table 37. Grifols Blood Product Revenue (US$ Million) and Gross Margin (2017-2022)
Table 38. Grifols Blood Product Product
Table 39. Grifols Blood Product Revenue Proportion of Blood Product by Product in 2021
Table 40. Grifols Blood Product Revenue Proportion of Blood Product by Application in 2021
Table 41. Grifols Blood Product Revenue Proportion of Blood Product by Geographic Area in 2021
Table 42. Grifols Recent Development
Table 43. Octapharma Corporation Information
Table 44. Octapharma Description and Business Overview
Table 45. Octapharma Blood Product Revenue (US$ Million) and Gross Margin (2017-2022)
Table 46. Octapharma Blood Product Product
Table 47. Octapharma Blood Product Revenue Proportion of Blood Product by Product in 2021
Table 48. Octapharma Blood Product Revenue Proportion of Blood Product by Application in 2021
Table 49. Octapharma Blood Product Revenue Proportion of Blood Product by Geographic Area in 2021
Table 50. Octapharma Recent Development
Table 51. Kedrion Corporation Information
Table 52. Kedrion Description and Business Overview
Table 53. Kedrion Blood Product Revenue (US$ Million) and Gross Margin (2017-2022)
Table 54. Kedrion Blood Product Product
Table 55. Kedrion Blood Product Revenue Proportion of Blood Product by Product in 2021
Table 56. Kedrion Blood Product Revenue Proportion of Blood Product by Application in 2021
Table 57. Kedrion Blood Product Revenue Proportion of Blood Product by Geographic Area in 2021
Table 58. Kedrion Recent Development
Table 59. LFB Group Corporation Information
Table 60. LFB Group Description and Business Overview
Table 61. LFB Group Blood Product Revenue (US$ Million) and Gross Margin (2017-2022)
Table 62. LFB Group Blood Product Product
Table 63. LFB Group Blood Product Revenue Proportion of Blood Product by Product in 2021
Table 64. LFB Group Blood Product Revenue Proportion of Blood Product by Application in 2021
Table 65. LFB Group Blood Product Revenue Proportion of Blood Product by Geographic Area in 2021
Table 66. Biotest Corporation Information
Table 67. Biotest Description and Business Overview
Table 68. Biotest Blood Product Revenue (US$ Million) and Gross Margin (2017-2022)
Table 69. Biotest Blood Product Product
Table 70. Biotest Blood Product Revenue Proportion of Blood Product by Product in 2021
Table 71. Biotest Blood Product Revenue Proportion of Blood Product by Application in 2021
Table 72. Biotest Blood Product Revenue Proportion of Blood Product by Geographic Area in 2021
Table 73. BPL Corporation Information
Table 74. BPL Description and Business Overview
Table 75. BPL Blood Product Revenue (US$ Million) and Gross Margin (2017-2022)
Table 76. BPL Blood Product Product
Table 77. BPL Blood Product Revenue Proportion of Blood Product by Product in 2021
Table 78. BPL Blood Product Revenue Proportion of Blood Product by Application in 2021
Table 79. BPL Blood Product Revenue Proportion of Blood Product by Geographic Area in 2021
Table 80. Shanghai RAAS Corporation Information
Table 81. Shanghai RAAS Description and Business Overview
Table 82. Shanghai RAAS Blood Product Revenue (US$ Million) and Gross Margin (2017-2022)
Table 83. Shanghai RAAS Blood Product Product
Table 84. Shanghai RAAS Blood Product Revenue Proportion of Blood Product by Product in 2021
Table 85. Shanghai RAAS Blood Product Revenue Proportion of Blood Product by Application in 2021
Table 86. Shanghai RAAS Blood Product Revenue Proportion of Blood Product by Geographic Area in 2021
Table 87. China Biologic Products Corporation Information
Table 88. China Biologic Products Description and Business Overview
Table 89. China Biologic Products Blood Product Revenue (US$ Million) and Gross Margin (2017-2022)
Table 90. China Biologic Products Blood Product Product
Table 91. China Biologic Products Blood Product Revenue Proportion of Blood Product by Product in 2021
Table 92. China Biologic Products Blood Product Revenue Proportion of Blood Product by Application in 2021
Table 93. China Biologic Products Blood Product Revenue Proportion of Blood Product by Geographic Area in 2021
Table 94. Hualan Biological Engineering Inc. Corporation Information
Table 95. Hualan Biological Engineering Inc. Description and Business Overview
Table 96. Hualan Biological Engineering Inc. Blood Product Revenue (US$ Million) and Gross Margin (2017-2022)
Table 97. Hualan Biological Engineering Inc. Blood Product Product
Table 98. Hualan Biological Engineering Inc. Blood Product Revenue Proportion of Blood Product by Product in 2021
Table 99. Hualan Biological Engineering Inc. Blood Product Revenue Proportion of Blood Product by Application in 2021
Table 100. Hualan Biological Engineering Inc. Blood Product Revenue Proportion of Blood Product by Geographic Area in 2021
Table 101. Beijing Tiantan Biological Products Corp Corporation Information
Table 102. Beijing Tiantan Biological Products Corp Description and Business Overview
Table 103. Beijing Tiantan Biological Products Corp Blood Product Revenue (US$ Million) and Gross Margin (2017-2022)
Table 104. Beijing Tiantan Biological Products Corp Blood Product Product
Table 105. Beijing Tiantan Biological Products Corp Blood Product Revenue Proportion of Blood Product by Product in 2021
Table 106. Beijing Tiantan Biological Products Corp Blood Product Revenue Proportion of Blood Product by Application in 2021
Table 107. Beijing Tiantan Biological Products Corp Blood Product Revenue Proportion of Blood Product by Geographic Area in 2021
Table 108. Pacific Shuanglin Corporation Information
Table 109. Pacific Shuanglin Description and Business Overview
Table 110. Pacific Shuanglin Blood Product Revenue (US$ Million) and Gross Margin (2017-2022)
Table 111. Pacific Shuanglin Blood Product Product
Table 112. Pacific Shuanglin Blood Product Revenue Proportion of Blood Product by Product in 2021
Table 113. Pacific Shuanglin Blood Product Revenue Proportion of Blood Product by Application in 2021
Table 114. Pacific Shuanglin Blood Product Revenue Proportion of Blood Product by Geographic Area in 2021
Table 115. Boya Bio-Pharmaceutical Corporation Information
Table 116. Boya Bio-Pharmaceutical Description and Business Overview
Table 117. Boya Bio-Pharmaceutical Blood Product Revenue (US$ Million) and Gross Margin (2017-2022)
Table 118. Boya Bio-Pharmaceutical Blood Product Product
Table 119. Boya Bio-Pharmaceutical Blood Product Revenue Proportion of Blood Product by Product in 2021
Table 120. Boya Bio-Pharmaceutical Blood Product Revenue Proportion of Blood Product by Application in 2021
Table 121. Boya Bio-Pharmaceutical Blood Product Revenue Proportion of Blood Product by Geographic Area in 2021
Table 122. Paisi Feike Biology Pharmacy Co., Ltd. Corporation Information
Table 123. Paisi Feike Biology Pharmacy Co., Ltd. Description and Business Overview
Table 124. Paisi Feike Biology Pharmacy Co., Ltd. Blood Product Revenue (US$ Million) and Gross Margin (2017-2022)
Table 125. Paisi Feike Biology Pharmacy Co., Ltd. Blood Product Product
Table 126. Paisi Feike Biology Pharmacy Co., Ltd. Blood Product Revenue Proportion of Blood Product by Product in 2021
Table 127. Paisi Feike Biology Pharmacy Co., Ltd. Blood Product Revenue Proportion of Blood Product by Application in 2021
Table 128. Paisi Feike Biology Pharmacy Co., Ltd. Blood Product Revenue Proportion of Blood Product by Geographic Area in 2021
Table 129. Xinjiang Deyuan Bioengineering Corporation Information
Table 130. Xinjiang Deyuan Bioengineering Description and Business Overview
Table 131. Xinjiang Deyuan Bioengineering Blood Product Revenue (US$ Million) and Gross Margin (2017-2022)
Table 132. Xinjiang Deyuan Bioengineering Blood Product Product
Table 133. Xinjiang Deyuan Bioengineering Blood Product Revenue Proportion of Blood Product by Product in 2021
Table 134. Xinjiang Deyuan Bioengineering Blood Product Revenue Proportion of Blood Product by Application in 2021
Table 135. Xinjiang Deyuan Bioengineering Blood Product Revenue Proportion of Blood Product by Geographic Area in 2021
Table 136. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Corporation Information
Table 137. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Description and Business Overview
Table 138. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Blood Product Revenue (US$ Million) and Gross Margin (2017-2022)
Table 139. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Blood Product Product
Table 140. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Blood Product Revenue Proportion of Blood Product by Product in 2021
Table 141. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Blood Product Revenue Proportion of Blood Product by Application in 2021
Table 142. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Blood Product Revenue Proportion of Blood Product by Geographic Area in 2021
Table 143. Shenzhen Weiguang Corporation Information
Table 144. Shenzhen Weiguang Description and Business Overview
Table 145. Shenzhen Weiguang Blood Product Revenue (US$ Million) and Gross Margin (2017-2022)
Table 146. Shenzhen Weiguang Blood Product Product
Table 147. Shenzhen Weiguang Blood Product Revenue Proportion of Blood Product by Product in 2021
Table 148. Shenzhen Weiguang Blood Product Revenue Proportion of Blood Product by Application in 2021
Table 149. Shenzhen Weiguang Blood Product Revenue Proportion of Blood Product by Geographic Area in 2021
Table 150. Shanxi Kangbao Corporation Information
Table 151. Shanxi Kangbao Description and Business Overview
Table 152. Shanxi Kangbao Blood Product Revenue (US$ Million) and Gross Margin (2017-2022)
Table 153. Shanxi Kangbao Blood Product Product
Table 154. Shanxi Kangbao Blood Product Revenue Proportion of Blood Product by Product in 2021
Table 155. Shanxi Kangbao Blood Product Revenue Proportion of Blood Product by Application in 2021
Table 156. Shanxi Kangbao Blood Product Revenue Proportion of Blood Product by Geographic Area in 2021
Table 157. Nanyue Biopharming Corporation Ltd Corporation Information
Table 158. Nanyue Biopharming Corporation Ltd Description and Business Overview
Table 159. Nanyue Biopharming Corporation Ltd Blood Product Revenue (US$ Million) and Gross Margin (2017-2022)
Table 160. Nanyue Biopharming Corporation Ltd Blood Product Product
Table 161. Nanyue Biopharming Corporation Ltd Blood Product Revenue Proportion of Blood Product by Product in 2021
Table 162. Nanyue Biopharming Corporation Ltd Blood Product Revenue Proportion of Blood Product by Application in 2021
Table 163. Nanyue Biopharming Corporation Ltd Blood Product Revenue Proportion of Blood Product by Geographic Area in 2021
Table 164. Global Blood Product Revenue by Type (2017-2022) & (US$ Million)
Table 165. Global Blood Product Revenue by Application (2017-2022) & (US$ Million)
Table 166. Global Blood Product Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 167. North America Blood Product Revenue by Country (2017-2022) & (US$ Million)
Table 168. North America Blood Product Revenue by Country (2023-2028) & (US$ Million)
Table 169. North America Blood Product Revenue by Type (2017-2022) & (US$ Million)
Table 170. North America Blood Product Revenue by Application (2017-2022) & (US$ Million)
Table 171. Asia-Pacific Blood Product Revenue by Region (2017-2028) & (US$ Million)
Table 172. Asia-Pacific Blood Product Revenue by Region (2023-2028) & (US$ Million)
Table 173. Asia-Pacific Blood Product Revenue by Type (2017-2022) & (US$ Million)
Table 174. Asia-Pacific Blood Product Revenue by Application (2017-2022) & (US$ Million)
Table 175. Europe Blood Product Revenue by Country (2017-2022) & (US$ Million)
Table 176. Europe Blood Product Revenue by Country (2023-2028) & (US$ Million)
Table 177. Europe Blood Product Revenue by Type (2017-2022) & (US$ Million)
Table 178. Europe Blood Product Revenue by Application (2017-2022) & (US$ Million)
Table 179. Latin America Blood Product Revenue by Country (2017-2022) & (US$ Million)
Table 180. Latin America Blood Product Revenue by Country (2023-2028) & (US$ Million)
Table 181. Latin America Blood Product Revenue by Type (2017-2022) & (US$ Million)
Table 182. Latin America Blood Product Revenue by Application (2017-2022) & (US$ Million)
Table 183. Middle East and Africa Blood Product Revenue by Country (2017-2022) & (US$ Million)
Table 184. Middle East and Africa Blood Product Revenue by Country (2023-2028) & (US$ Million)
Table 185. Middle East and Africa Blood Product Revenue by Type (2017-2022) & (US$ Million)
Table 186. Middle East and Africa Blood Product Revenue by Applicatio
  • Global Blood Product Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 151
    According to our LPI (LP Information) latest study, the global Blood Product market size was valued at US$ 27700 million in 2023. With growing demand in downstream market, the Blood Product is forecast to a readjusted size of US$ 47120 million by 2030 with a CAGR of 7.9% during review period. The research report highlights the growth potential of the global Blood Product market. Blood Product are expected to show stable growth in the future market. However, product differentiation, reduc......
  • Blood Bank - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 121
    This report studies the Blood Banking market, and blood banking refers to the process of collecting, separating, and storing blood. A blood bank is a center where blood gathered as a result of blood donation is stored and preserved for later use in blood transfusion. The term "blood bank" typically refers to a division of a hospital where the storage of blood product occurs and where proper testing is performed (to reduce the risk of transfusion related adverse events). However, it sometimes ref......
  • Global Blood Bank Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 05-Dec-2023        Price: US 3380 Onwards        Pages: 118
    Market Overview of Global Blood Bank market: According to our latest research, the global Blood Bank market looks promising in the next 5 years. As of 2022, the global Blood Bank market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Blood Bank market, with a systematical de......
  • Global Blood Product Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Oct-2023        Price: US 3380 Onwards        Pages: 106
    Market Overview of Global Blood Product market: According to our latest research, the global Blood Product market looks promising in the next 5 years. As of 2022, the global Blood Product market was estimated at USD 36690.5 million, and it's anticipated to reach USD 49068.0 million in 2028, with a CAGR of 4.96% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Blood Product market......
  • Global Cord Blood Banking Services Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 19-Oct-2023        Price: US 3380 Onwards        Pages: 112
    Market Overview of Global Cord Blood Banking Services market: According to our latest research, the global Cord Blood Banking Services market looks promising in the next 5 years. As of 2022, the global Cord Blood Banking Services market was estimated at USD 26210.34 million, and it's anticipated to reach USD 46339.39 million in 2028, with a CAGR of 9.96% during the forecast years. A cord blood bank is a facility which stores umbilical cord blood for future use. Both private a......
  • Global Blood Products Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Sep-2023        Price: US 3380 Onwards        Pages: 118
    Market Overview of Global Blood Products market: According to our latest research, the global Blood Products market looks promising in the next 5 years. As of 2022, the global Blood Products market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Blood Products market, with a......
  • Blood Products Companies in China
    Published: 07-Sep-2023        Price: US 1800 Onwards        Pages: 81
    This study focuses on China's Blood Products industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of g......
  • Blood Products Markets in China
    Published: 07-Sep-2023        Price: US 4000 Onwards        Pages: 274
    China's demand for Blood Products has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, indust......
  • Blood Products Industry Forecasts - China Focus
    Published: 07-Sep-2023        Price: US 1800 Onwards        Pages: 144
    This study focuses on China's Blood Products industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of goods and services. The ......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs